SET Domain, Bifurcated 2 (SETDB2) Peptid
SETDB2
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN983609
Kurzübersicht für SET Domain, Bifurcated 2 (SETDB2) Peptid (ABIN983609)
Target
SETDB2
(SET Domain, Bifurcated 2 (SETDB2))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-SETDB2 antibody (Catalog #: ARP48955_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- SETDB2 (SET Domain, Bifurcated 2 (SETDB2))
-
Hintergrund
-
Proteins that contain a SET domain, such as SETDB2, modulate gene expression epigenetically through histone H3 methylation. SETDB2 is likely a histone H3 methyltransferase, as it contains both the active site and flanking cysteine residues required for catalytic activity.
Alias Symbols: CLLD8, CLLL8, KMT1F, C13orf4
Protein Size: 707 -
Molekulargewicht
- 77 kDa
-
Gen-ID
- 83852
-
NCBI Accession
- NM_001160308
Target
-
Sie sind hier:
